Valuation Roche Holding AG London S.E.

Stocks

Market Closed - London S.E. Other stock markets 11:20:00 2026-07-29 EDT			5-day change	1st Jan Change
323.90 ^CHF	0.00%		0.00%	-1.29%

07-27	Sika raises annual sales-growth outlook after strong first-half performance	RE
07-27	IDEAYA Biosciences Advances IDE892 Into Phase 1/2 Monotherapy Expansion	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	306,810	239,812	197,073	205,191	262,098	289,246	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	10.36%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	299,991	293,210	285,273
Change	-	-21.41%	-15.51%	3.13%	25.04%	7.81%	-2.26%	-2.71%
P/E	23.4x	18.9x	17.1x	24.8x	20.5x	20x	17.8x	16.4x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	7.21x	6.06x	5.12x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1.6x	1.4x	1.92x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.62x	4.42x	4.21x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.79x	4.48x	4.15x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	11.9x	10.8x	9.86x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	13.2x	12.1x	11x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	19.6x	18x	16.2x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	5.11%	5.57%	6.19%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	10	10.24	10.51
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	2.76%	2.83%	2.91%
EPS ²	16.2	15.37	14.31	10.31	16.04	18.05	20.27	22
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	55.4%	50.5%	47.8%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,645	65,471	68,719
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,278	27,191	28,937
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,790	24,323	25,904
Net income ¹	13,930	12,421	11,498	8,277	12,880	14,580	16,365	17,605
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	10,745	3,963	-3,973
Reference price ²	379.10	290.50	244.50	255.50	328.20	361.70	361.70	361.70
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	796,766	-	-
Announcement Date	2/3/22	2/2/23	2/1/24	1/30/25	1/29/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	36.25x	12.94x	27.18x	0.55%	1,089B
JOHNSON & JOHNSON	28.59x	6.53x	18.09x	2.01%	643B
ABBVIE INC.	33.13x	7.75x	15.94x	2.61%	465B
NOVARTIS AG	22.65x	5.84x	14.57x	2.74%	303B
ASTRAZENECA PLC	22.03x	4.53x	12.8x	1.93%	267B
NOVO NORDISK A/S	14.79x	5.48x	11.3x	3.38%	226B
AMGEN INC.	25.81x	6.73x	11.86x	2.57%	212B
GILEAD SCIENCES, INC.	-48.4x	5.8x	32.01x	2.45%	167B
PFIZER INC.	12.82x	3.13x	7.91x	6.82%	144B
Average	16.41x	6.53x	16.85x	2.79%	390.62B
Weighted average by Cap.	25.20x	8.24x	19.35x	2.04%